Authors
Latest:
Current Treatment Approaches for Relapsed/Refractory Diffuse Large B-Cell LymphomaRelapsed treatment has evolved with CAR T, bispecific antibodies, and immunotherapies.
Latest:
How PBMs Can Help Rein in Drug SpendingFormulary changes, utilization management, and a lack of transparency upset a lot of members, which hides a lot of good things that pharmacy benefit managers do.
Latest:
What Pharmacists Need to Know About Omega-3 Fatty Acids and Fish Oil SupplementsMany patients turn to fish oil supplements to gain the benefits of omega-3 fatty acids, but there are important considerations pharmacists should be aware of before recommending fish oil supplements to their customers.
Latest:
Behind the Counter: Mastering Pseudoephedrine and Other Restricted OTC MedicationsMelissa Zinszer, PharmD, CDCES, explores the multifaceted role of pharmacists and healthcare providers in managing behind-the-counter medications, addressing patient concerns, optimizing over-the-counter therapy, and ensuring safe, effective treatment through careful symptom assessment and consideration of drug interactions.
Latest:
New Tool Helps Providers Navigate Adalimumab BiosimilarsThe tool consolidates and highlights key features that would be considered when choosing a biosimilar adalimumab.
Latest:
Preventing Adverse Drug Events: A Call to Action for PharmacistsNational Adverse Drug Event Awareness Day was established to promote awareness, drive policy changes, and encourage health care professionals and patients to prioritize medication safety.
Latest:
Explore Ovarian Cancer Treatments Through Clinical TrialsGuidelines typically recommend debulking surgery, plus systemic chemotherapy for most patients.
Latest:
Oral Oncolytics Expand Armamentarium in HR+/HER– Early-Stage Breast Cancer in Adjuvant SettingNew agents can offer a more tailored approach to therapy selection.
Latest:
Clinical Pharmacists Can Improve Cost Savings Through Medication Assistance Programs in Primary CarePharmacists should continue to seek out opportunities to be involved in family medicine and chronic disease state management to make meaningful impacts on care.
Latest:
Survey: Retail Pharmacists Optimistic About Biosimilars, Still Have QuestionsWith the FDA approval and launch of the first interchangeable biosimilar in the United States in 2021, retail pharmacists are poised to play an increasing role in the future uptake of biosimilars.
Latest:
Direct Oral Anticoagulant Use for Left Ventricular Thrombus TreatmentAn overview of the use of direct oral anticoagulants as an alternative to warfarin in the treatment of left ventricular thrombus.
Latest:
Three Ways Community Pharmacies Can Partner With Academia to Implement Patient Care InitiativesMany faculty members are adept at training and teaching pharmacists and pharmacy technicians how to perform physical exams and tests.
Latest:
EmPATHy: More Empathy Toward Patients Improves Outcomes in Their HealthBy empathizing with patients and creating an environment where patients feel comfortable and open to sharing, pharmacists can increase compliance and adherence.
Latest:
Commonly Overlooked Adverse Effects in the Community, Clinical Pharmacy SettingsAlthough pharmacists possess a wealth of knowledge on AEs, it remains a monumental task to recall the clinical significance of every AE, even with the most commonly used medications.
Latest:
Pediatric Weight is Crucial to Perfecting the DoseEvidence indicates that up to 25% of all prescriptions for children could be dosed inappropriately, making it the most common type of medication administration error.
Latest:
Pharmacists Help Patients Navigate Vaccine SchedulesMany patients may struggle to understand the complex immunization schedules compiled by the CDC.
Latest:
AI Can Help Bridge Disparities in Cancer Care Through Digital PlatformsCollaboration between AI-based platforms and health care organizations offers promising results.
Latest:
Interactive Case Studies: September 2023Cases highlight an acute subdural hematoma and chronic obstructive pulmonary disease.
Latest:
Zongertinib: A Promising New TKI for HER2-Mutated NSCLCIf approved, zongertinib may be a new first-line oral tyrosine kinase inhibitor (TKI) for patients with HER2-mutated non-small cell lung cancer (NSCLC), a transformative step in TKI drug development.
Latest:
Pharmacogenomics Offers a Glimpse Into the Future of PharmacyOne day soon, including pharmacogenomics testing for all patients will be essential for precise prescribing.
Latest:
Targeting DLL3 in Small Cell Lung Cancer and Other Neuroendocrine CarcinomasDLL3 is an emerging therapeutic target in small cell lung cancer and other neuroendocrine carcinomas, with 1 FDA-approved therapy and several others under investigation.
Latest:
Understanding the Role of Oncology Pharmacists in Academic vs Community Cancer CentersTheir expertise complements multidisciplinary teams in a variety of clinical settings.
Latest:
Staff Pharmacists Discuss Updated Carboplatin Drug Shortage Mitigation Strategies at the University of Illinois at Chicago Oncology Clinic PharmacyAfter carboplatin joined the growing list of drug shortages, staff pharmacists acted to minimize the impact on patients.
Latest:
Clinical Overview: Mavacamten for Symptomatic Obstructive Hypertrophic CardiomyopathyMavacamten is a first-in-class selective allosteric modulator of beta cardiac myosin ATPase for the treatment of symptomatic obstructive hypertrophic cardiomyopathy.
Latest:
Therapies in the Pipeline for Prostate CancerNew potential medications may continue to expand the role of targeted agents.
Latest:
Tip of the Week: We Are All Clinician-ManagersThe evolution of health care to a more patient-centric focus suggests an even greater marriage between the concepts of manager and clinician.
Latest:
Microbiology Quality Control Helps the Cell and Gene Therapy Segment Cure the IncurableWith the continued advancement and approval of cell and gene therapies, the need for trustworthy microbiology quality control solutions is at an all-time high.
Latest:
How Can Pharmacies Close the Gap on Vaccine Uptake?Pharmacists and the pharmacies they support are in a strong position to increase vaccination rates and address any questions related to vaccine hesitancy.
Latest:
Critical Success Factors for Commercializing Specialty Drugs, Cell and Gene TherapiesAlthough payers have become somewhat accustomed to the high cost of specialty drugs, the price tags for gene therapies are causing “sticker shock.”
Latest:
Once-Daily Oral Pill for Plaque Psoriasis Shows PromiseDeuvacracitinib (Sotyktu), which the FDA approved in September 2022, is a first-of-its-class tyrosine kinase 2 inhibitor and a member of the Janus kinase family.
